QQQ $ 451.64 $ -0.92 (-0.2 %)
DIA $ 399.14 $ -0.07 (-0.02 %)
SPY $ 528.49 $ -1.09 (-0.21 %)
TLT $ 92.06 $ -0.09 (-0.1 %)
GLD $ 220.06 $ -0.86 (-0.39 %)
$ 0.1995
-- x --
-- x --
-- - --
$ 0.15 - $ 0.35
3,000
na
na
$ 0.70
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 this-pharma-co-kicks-off-fda-approval-process-for-cbd-based-treatment-of-chronic-pain

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) announced on Monday that it has submitted its letter of applic...

 534-revenue-surge-unveiled-by-israeli-cbd-focused-pharma-company-exceeding-expectations

Innocan Pharma's 2023 earnings report: Revenue soars 534%, operating loss down 61%, $1.5M capital raise. CEO shares strateg...

 cbd-focused-pharma-co-innocan-reveals-433-yoy-increase-in-2023-revenue-as-it-pursues-fda-approval

Cannabinoid-focused pharmaceutical company Innocan Pharma Corp expects preliminary revenues of $4.89m in Q4 of fiscal 2023, rep...

 more-cannabis-funding-for-fda-and-product-expansion-how-this-pharma-tech-company-is-doing-it

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has closed the second and final tranche of its previously anno...

 cbd-focused-pharma-co-seeks-funding-to-revolutionize-healthcare

Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) has entered into an agreement with Research Capital Corporatio...

 innocan-pharmas-q2-2023-reports-gross-profit-growth-driven-by-robust-subsidiary-sales

Innocan Pharma Corporation (CSE: INNO)(FSE: IP4) (OTC: INNPF), a pharmaceutical technology firm specializing in innovative drug...

Core News & Articles

GAINERS: Choom Holdings (OTC:CHOOF) shares closed up 900.00% at $0.0001

Core News & Articles

GAINERS: Australis Capital (OTC:AUSAF) shares closed up 9900.00% at $0.0001

 innocan-pharma-secures-14m-via-private-placement

Innocan Pharma Corporation (OTC: INNPF) (CSE:INNO) (FSE:IP4) has closed a non-brokered private placement offering of 8.4 millio...

 innocan-pharma-to-secure-up-to-3m-via-private-placement-of-units-at-a-9-prime-above-share-price

Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) intends to complete a non-brokered private placement of up to 17...

Core News & Articles

GAINERS: Craftport Cannabis (OTC:BHHKF) shares closed up 580.00% at $0.00

 innocan-pharma-q1-revenue-grows-500-yoy-here-is-what-you-need-to-know

Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) released its financial results for the three months ended March ...

 innocan-pharma-fy22-revenue-grows-1205-to-26m-here-is-what-you-need-to-know

Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) released its audited financial results for the year ended Decemb...

 can-liposomal-cbd-injection-help-dogs-with-polyarthritis-innocan-pharma-reports-clinical-success

Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) reported clinical success in its Canine (dogs) Compassionate Car...

 innocan-pharma-q3-revenue-grows-700-yoy-here-is-what-you-need-to-know

Innocan Pharma Corporation (OTCQB: INNPF) (CSE:INNO) (FSE:IP4) released its financial results for the three and nine months end...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION